TIBER CREEK HEALTH STRATEGIES, INC.

Biopharma

Latest filing Jul 19, 2026

Government Relations.

$2.7M

Reported income

Medicare/Medicaid leads by disclosed activity

Filings

Most recent on Jul 19, 2026

Clients represented

TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS) leads by reported income

Lobbyists employed

COREY MALMGREN appears most prominently

Reported Income Over Time

Annual totals based on disclosed filing amounts.

2025

$1.1M19 filings

2026

$1.7M31 filings

Client Portfolio

The clients this firm represents, ranked by disclosed filing amounts.

TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS)

Biopharma

5 filingsLatest Jul 18, 2026

Government relations.

$320K

ELI LILLY AND COMPANY

Biopharma

4 filingsLatest Jul 19, 2026

Pharmaceutical company.

$320K

What They Lobby On

Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.

Medicare/Medicaid

MMM

10 mentions10 filingsLatest Jul 18, 2026

$550K

apportioned income

HOUSE OF REPRESENTATIVES10SENATE8

Government Touchpoints

The entities named in disclosed activities are the clearest available signal for where the firm is directing attention.

01HOUSE OF REPRESENTATIVES

10 mentions

02SENATE

8 mentions

Industry Profile

AI-classified industry allocation based on the firm's filing activity.

Confidence

91%

Industry count

Biopharma

86%

Healthcare

14%

Registrant industry was derived from the weighted mix of labeled clients across filings, spend, and activity volume.

Recent Filings

The latest disclosures filed by this firm.

TIBER CREEK GROUP (OBO JAZZ PHARMACEUTICALS)Q2Y

2026 second quarter0 issues0 lobbyists

$50K

Jul 19, 2026

ELI LILLY AND COMPANYQ2Y

2026 second quarter0 issues0 lobbyists

$80K

Jul 19, 2026

TIBER CREEK HEALTH STRATEGIES, INC.

Reported Income Over Time

Client Portfolio

What They Lobby On

Medicare/Medicaid

Government Touchpoints

Industry Profile

Recent Filings

Lobbyists Employed